Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial

545

Citations

22

References

2005

Year

Norio Kohno, Kenjiro Aogi, Hironobu Minami, Seigo Nakamura, Taro Asaga, Yuichi Iino, Toru Watanabe, Carsten Goessl, Yasuo Ohashi, Shigemitsu Takashima

Journal of Clinical Oncology

Abstract

Zoledronic acid significantly reduced skeletal complications compared with placebo across multiple end points in Japanese women with bone metastases from breast cancer.

References

	Year	Citations

Page 1